Case 1: Clinical Presentation

Similar documents
Case 1. Background. Presenting Symptoms. Schecter Case1 Differential Diagnosis of TB 1

My heart is racing. Managing Complex Cases. Case 1. Case 1

TB: Management in an era of multiple drug resistance. Bob Belknap M.D. Denver Public Health November 2012

TB Classification (ATS/CDC)

Diagnosis and Treatment of Tuberculosis, 2011

Clinical Presenation & Diagnosis of Tuberculosis Disease

What you need to know about diagnosing and treating TB: a preventable, fatal disease. Bob Belknap M.D. Denver Public Health November 2014

Tuberculosis (TB) and Infection Control PICNET Conference April 12, 2013

Tuberculosis Tools: A Clinical Update

Scott Lindquist MD MPH Tuberculosis Medical Consultant Washington State DOH and Kitsap County Health Officer

Tuberculosis in Primary Care COC GTA Spring Symposium Dr Elizabeth Rea April 2013

Northwestern Polytechnic University

Contact Investigation and Prevention in the USA

Fundamentals of Tuberculosis (TB)

TB Grand Rounds. Reynard McDonald, MD & Henry Fraimow, MD January 30, Outline

INDEX CASE INFORMATION

Treatment of Tuberculosis, 2017

Rehuka Khurana, MD, MPH has the following disclosures to make:

Diagnosis and Medical Management of Latent TB Infection

Objectives. 3HP and Flu Syndrome What is the Underlying Mechanism? Case #1 3/23/2016. Christina T. Fiske, MD MPH March 30, 2016

Tuberculosis Facts. TB is not spread by: Sharing food and drink Shaking someone s hand Touching bed lines or toilet seats

Tuberculosis: A Provider s Guide to

Managing the Patients Response to TB Treatment

Tuberculosis and Diabetes Dec. 10, 2009 Dean Schillinger, M.D. and Gisela Schecter, M.D., M.P.H. 1 of 18

TB Nurse Assessment. Ginny Dowell, RN, BSN October 21, 2015

TB in Corrections Phoenix, Arizona

TB In Detroit 2011* Early TB: Smudge Sign. Who is at risk for exposure to or infection with TB? Who is at risk for TB after exposure or infection?

Cooperation. Tuberculosis Panel on Tips from the Field. Introductions. Katie Dickerson, RN. David Miller, RN. Moni Muraki

Treatment of TB Infection Lisa Y. Armitige, MD, PhD April 7, 2015

Role of Surgery in the Management of TB. Lee Reichman, MD & Paul Bolanowski, MD

Patient Background. Role of Surgery in the Management of TB. Patient Background CXR 3/20/02

Pre-Treatment Evaluation. Treatment of Latent TB Infection (LTBI) Initiating Treatment: Patient Education. Before initiating treatment for LTBI:

Analysis. Answers. Action. Saturday Night Fever. Shaka Brown Capital Congress

HEALTH SERVICES POLICY & PROCEDURE MANUAL

Treatment of Tuberculosis

PREVENTION OF TUBERCULOSIS. Dr Amitesh Aggarwal

TB Intensive San Antonio, Texas December 1-3, 2010

TB Nurse Case Management San Antonio, Texas April 9-11, 2013

What s New in TB Infection Control?

Patient History 1. Patient History 2. Social History. The Role of Surgery in the Management of TB. Reynard McDonald, MD & Paul Bolanowski, MD

Ian Kitai TB Specialist. Division of Infectious Diseases Sickkids

The Dr. Jae Yang Lecture: An Overview of the Radiographic Picture of TB

Instructions: Please bring these forms to your Physical Examination & TB Test and have the Doctor fill them out. (Where applicable)

2017/2018 Annual Volunteer Tuberculosis Notice

Recognizing MDR-TB in Children. Ma. Cecilia G. Ama, MD 23 rd PIDSP Annual Convention February 2016

Tuberculosis and Diabetes Mellitus. Lana Kay Tyer, RN MSN WA State Department of Health TB Nurse Consultant

Tuberculosis in the Traveler

TB Contact Investigation

Errors in Dx and Rx of TB

Property of Presenter. Not for Reproduction DENVER TB COURSE: CHALLENGING CLINICAL PRESENTATIONS

Clinical Radiological Pathological Conference

SA TB Guidelines The interface with Advanced Clinical Care

What the Primary Physician Should Know about Tuberculosis. Topics for Discussion. Life Cycle of M. tuberculosis

Investigation of Contacts of Persons with Infectious Tuberculosis, 2005

Tips and Tricks for Diagnosing and Treating Tuberculosis

Utilizing All the Tools in the TB Toolbox

Stop TB Poster (laminated copies are available from TB Control: )

Questions and Answers About

Contact Investigation

6/8/2018 TB TREATMENT. Bijan Ghassemieh, MD Seattle TB Clinical Intensive Disclosures. None

Disclosures. Updates in TB for the PCP: Opportunities for Prevention. Objectives PART 1: WHY TEST? 4/14/2016. None

TB in Prisons and Jails Albuquerque, New Mexico November 28, 2012

Overview Treatment of latent TB infection Meta-analysis 36 months of IPT Screening for TB Adverse events INH Resistance IPT & ART TST Conclusions

Primary Care and TB Control Dr Helen Booth Consultant Thoracic Physician, UCLH Clinical Lead, Integrated TB NCL-Service

Symptoms Latent TB Active TB

The diagnosis of active TB

South African HIV Clinicians Society Managing adult treatment through case study discussion

Latent TB Infection Treatment

What the Primary Physician Should Know about Tuberculosis. Topics for Discussion. Global Impact of TB

Tuberculosis What you need to know. James Zoretic M.D., M.P.H. Regions 2 and 3 Director

RHEUMATOLOGY PATIENT HISTORY FORM

Introduction to TB Nurse Case Management Online February 4, 11, 18 and 25, 2015

TB Intensive Houston, Texas. Childhood Tuberculosis Kim Connelly Smith. November 12, 2009

Step 1. CDC Framework for Program Evaluation. Stakeholders Maryland Evaluation Team. Identify Stakeholders

TB is Global. Latent TB Infection (LTBI) Sharing the Care: Working Together. September 24, 2014

Etiological Agent: Pulmonary Tuberculosis. Debra Mercer BSN, RN, RRT. Definition

NORTHERN VIRGINIA PULMONARY AND CRITICAL CARE ASSOCIATES, P.C.

DR-TB Patient Treatment Log Book

Drug Resistant Tuberculosis Self-reporting of Drugrelated. During Treatment

Interpretation of Chest Radiographs Paul Christensen, MD 10/21/09. Diagnostic Evaluation. Medical Evaluation & CXR Interpretation.

Profile of Tuberculosis Infection among Current HIV+ Patients at the Philippine General Hospital

What you need to know about diagnosing and treating TB: a preventable, fatal disease. Bob Belknap M.D. Denver Public Health November 2013

Diagnosis and Medical Management of TB Infection Lisa Y. Armitige, MD, PhD September 12, TB Nurse Case Management September 12 14, 2017

Monica Manandhar. 2 ND YEAR RESEARCH ELECTIVE RESIDENT S JOURNAL Volume V, A. Study Purpose and Rationale

TB Clinical Guidelines: Revision Highlights March 2014

TUBERCULOSIS. What you need to know BECAUSE...CARING COMES NATURALLY TO US

What is cancer? l Cancer is a group of several diseases caused by the abnormal growth of cells.

Diagnosis & Medical Case Management of TB Disease. Lisa Armitige, MD, PhD October 22, 2015

Managing Complex TB Cases Diana M. Nilsen, MD, RN

Tuberculosis Infection in the US Military

Pediatric TB Lisa Armitige, MD, PhD September 28, 2011

3/25/2012. numerous micro-organismsorganisms

Mycobacterial Infections: What the Primary Provider Should Know about Tuberculosis

Treatment of MDR-TB in high HIV- prevalence settings. Hind Satti, M.D. PIH-Lesotho October 20, 2008

Clinical Practice Guideline

The Public Health Impact of TB in the Correctional System. Sarah Bur, RN, MPH Federal Bureau of Prisons Infection Prevention and Control Officer

Case Study: TB-HIV co-infection

Latent tuberculosis infection

Transcription:

Impostors and Preconceived Notions: Lessons Learned in TB Diagnosis & Treatment Tuberculosis Nursing Workshop June 1, 2015 Christopher Spitters, MD, MPH Tuberculosis Clinic Public Health Seattle & King County Case 1: Clinical Presentation 29 y/o Mexican male 30 pounds weight loss, fever, dry cough, back pain over the past 3-4 months Left wrist ulcer for 3 weeks; no response to treatment with TMP/SMX No prior TB diagnosis or treatment Entered US 4 years ago Itinerant work in the fields 1

2

3

Case 1: Laboratory Findings TST 00mm/QFT negative Sputum smear and NAAT negative BAL AFB-smear, NAAT negative BAL and sputum fungal smears negative TBBx non necrotizing granulomata Wrist wound necrotizing and nonnecrotizing granulomata Fungal serology pending Case 1: Management INH/RIF/PZA/EMB started Case 1: Final Diagnosis Coccidioides immitis/posadasii recovered from skin wound, BAL, sputum, and spinal lesion Cocci titer 1:1024 Histo Ab negative Fluconazole started TB medications discontinued 4

Case 2: Clinical Presentation 48 y/o African American female Homeless, schizophrenic Smoking 1ppd since age 20 Coughing for 20 years Not losing weight (6-3 ; 145lbs, BMI 18) Denies fever, night sweats Case 2: Chest Radiograph Case 2: Laboratory Findings TST 07mm Sputum smear negative x3 NAAT negative x1 Discharged on empiric 4-drug therapy to TB control follow-up 5

Case 2: Final Diagnosis AFB cultures negative 5-pound weight loss Follow-up CXR unchanged CT guided needle biopsy: adenocarcinoma of the lung Case 3: Clinical Presentation 55 y/o Peruvian woman Cough, sputum, blood streaked sputum, weight loss, fatigue Started 4-drug anti-tb therapy 2 months ago in Peru No clinical improvement Case 3: Chest CT 6

Case 3: Final Diagnosis Sputum AFB smears and TB PCR negative Sputum sample processed for ova and parasites showing a paragonimus species egg Rx: Praziquantel 75 mg/kg/day in three divided doses, for three days Case 1-3: Lessons Learned TB has a lot of overlap with other serious conditions Many patients with confirmed TB start out with negative smears and NAAT, but it s a setting in which to be skeptical If empiric treatment is started, it should be accompanied by ongoing evaluation and monitoring for other causes until TB is confirmed Differential Diagnosis Community acquired pneumonia Malignancy Lung abscess Non-TB mycobacteria Fungal infection Parasite (e.g., paragonimiasis) Sarcoidosis Rheumatologic disease (e.g., Wegener s, RA) Other systemic infections (e.g., brucellosis, melioidosis, relapsing fever, etc.) 7

Case 4: Fatigue 43 y/o HIV-negative male with fully-sensitive sputum smear-positive pulmonary TB Baseline CBC/DIFF/CMP normal 4 week follow-up AFB smears negative Weight up 2 lbs Fatigue and dizziness Case 4: Next Steps LFTs normal Treatment continued Still fatigued and LFTs normal again at 6 weeks Telephone call from primary care at 7 weeks Case 5: Fatigue Revisited 34 y/o Korean male with inactive pulmonary TB Started INH 2 ½ months ago Last clinic visit 2 weeks ago. Adverse events checklist negative. Month 3 dispensed Now reports his family told him to come to clinic because his eyes look yellow Has not noticed much except feeling a lot more tired than usual for about 4-6 weeks and loss of appetite for about 2 weeks 8

Case 5: Next Steps INH stopped and LFTs drawn. ALT 950, AST 700, total bilirubin 4.2 Severe isoniazid liver injury Hospitalized and transferred to transplant center Peak ALT ~2000, peak bilirubin 25 Recovered. 6 weeks to normal LFTs Subsequently completed RIF x 4 months Case 5: Post-event Interview At month 1 and 2 clinic visits was asked a list of questions to which the answer was no Reported never being reminded after the first visit what side effects to watch for Understood less English than he portrayed Never had nausea, vomiting or abd pain Did a Google search on his symptoms Cases 4&5: Lessons Learned Fatigue and anorexia may be more sensitive indicators of liver injury than nausea/pain Fatigue may be due to something serious other than liver injury (e.g., anemia, myocardial ischemia, malignancy) Remind patients what side effects to look for at each encounter and to report all side effects promptly Nodding yes may mean I want to be cooperative but do not understand you. If you think about searching the Internet for symptoms, please hold medications and call the clinic. Do not re-start until told to do so. 9

Questions? Comments? christopher.spitters@kingcounty.gov 10